101 related articles for article (PubMed ID: 2334900)
1. Blockage of autonomous growth of ACHN cells by anti-renal cell carcinoma monoclonal antibody 5F4.
Kochevar J
Cancer Res; 1990 May; 50(10):2968-72. PubMed ID: 2334900
[TBL] [Abstract][Full Text] [Related]
2. Transforming growth factor-beta1 and renal cell cancer: cell growth, mRNA expression and protein production of cytokines.
Shimabukuro T; Ohmoto Y; Naito K
J Urol; 2003 May; 169(5):1865-9. PubMed ID: 12686863
[TBL] [Abstract][Full Text] [Related]
3. Anti-CD26 monoclonal antibody-mediated G1-S arrest of human renal clear cell carcinoma Caki-2 is associated with retinoblastoma substrate dephosphorylation, cyclin-dependent kinase 2 reduction, p27(kip1) enhancement, and disruption of binding to the extracellular matrix.
Inamoto T; Yamochi T; Ohnuma K; Iwata S; Kina S; Inamoto S; Tachibana M; Katsuoka Y; Dang NH; Morimoto C
Clin Cancer Res; 2006 Jun; 12(11 Pt 1):3470-7. PubMed ID: 16740772
[TBL] [Abstract][Full Text] [Related]
4. Trichostatin inhibits the growth of ACHN renal cell carcinoma cells via cell cycle arrest in association with p27, or apoptosis.
Park WH; Jung CW; Park JO; Kim K; Kim WS; Im YH; Lee MH; Kang WK; Park K
Int J Oncol; 2003 May; 22(5):1129-34. PubMed ID: 12684681
[TBL] [Abstract][Full Text] [Related]
5. Targeting beta2-microglobulin mediated signaling as a novel therapeutic approach for human renal cell carcinoma.
Nomura T; Huang WC; Seo S; Zhau HE; Mimata H; Chung LW
J Urol; 2007 Jul; 178(1):292-300. PubMed ID: 17499801
[TBL] [Abstract][Full Text] [Related]
6. Preparation of a monoclonal antibody to a melanoma growth-stimulatory activity released into serum-free culture medium by Hs0294 malignant melanoma cells.
Lawson DH; Thomas HG; Roy RG; Gordon DS; Chawla RK; Nixon DW; Richmond A
J Cell Biochem; 1987 Jul; 34(3):169-85. PubMed ID: 3611199
[TBL] [Abstract][Full Text] [Related]
7. [Renal cancer specific antitumor activities of a mouse monoclonal antibody K2.7 to human renal cell carcinoma].
Kinouchi T; Kotake T
Hinyokika Kiyo; 1992 Nov; 38(11):1325-31. PubMed ID: 1485589
[TBL] [Abstract][Full Text] [Related]
8. Sensitization of human renal cell carcinoma cells to cis-diamminedichloroplatinum(II) by anti-interleukin 6 monoclonal antibody or anti-interleukin 6 receptor monoclonal antibody.
Mizutani Y; Bonavida B; Koishihara Y; Akamatsu K; Ohsugi Y; Yoshida O
Cancer Res; 1995 Feb; 55(3):590-6. PubMed ID: 7834629
[TBL] [Abstract][Full Text] [Related]
9. Monoclonal antibodies to kidney and tumor-associated surface antigens of human renal cell carcinoma.
Luner SJ; Ghose T; Chatterjee S; Cruz HN; Belitsky P
Cancer Res; 1986 Nov; 46(11):5816-20. PubMed ID: 3530441
[TBL] [Abstract][Full Text] [Related]
10. Expression of high affinity interleukin-4 receptors on human renal cell carcinoma cells and inhibition of tumor cell growth in vitro by interleukin-4.
Obiri NI; Hillman GG; Haas GP; Sud S; Puri RK
J Clin Invest; 1993 Jan; 91(1):88-93. PubMed ID: 8423237
[TBL] [Abstract][Full Text] [Related]
11. Targeted therapy of experimental renal cell carcinoma with a novel conjugate of monoclonal antibody 138H11 and calicheamicin thetaI1.
Knoll K; Wrasidlo W; Scherberich JE; Gaedicke G; Fischer P
Cancer Res; 2000 Nov; 60(21):6089-94. PubMed ID: 11085532
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of angiogenesis via FGF-2 blockage in primitive and bone metastatic renal cell carcinoma.
Cenni E; Perut F; Granchi D; Avnet S; Amato I; Brandi ML; Giunti A; Baldini N
Anticancer Res; 2007; 27(1A):315-9. PubMed ID: 17352248
[TBL] [Abstract][Full Text] [Related]
13. Reactivities of mouse monoclonal antibody K2.7 to renal cancers in complement dependent cytotoxicity and antibody dependent cell-mediated cytotoxicity.
Kinouchi T; Bander NH; Kotake T
J Urol; 1995 Jul; 154(1):288-92. PubMed ID: 7776448
[TBL] [Abstract][Full Text] [Related]
14. Over expression of inhibitor of caspase 3 activated deoxyribonuclease in human renal cell carcinoma cells enhances their resistance to cytotoxic chemotherapy in vivo.
Hara S; Miyake H; Arakawa S; Kamidono S; Hara I
J Urol; 2001 Dec; 166(6):2491-4. PubMed ID: 11696816
[TBL] [Abstract][Full Text] [Related]
15. A renal cell carcinoma neoplastic antigen detectable by immunohistochemistry is defined by a murine monoclonal antibody.
Kochevar J
Cancer; 1987 Jun; 59(12):2031-6. PubMed ID: 3552200
[TBL] [Abstract][Full Text] [Related]
16. Production of human hematopoietic survival and growth factor by a myeloid leukemia cell line (KPB-M15) and placenta as detected by a monoclonal antibody.
Hiraoka A; Ohkubo T; Fukuda M
Cancer Res; 1987 Oct; 47(19):5025-30. PubMed ID: 3304620
[TBL] [Abstract][Full Text] [Related]
17. Development and characterization of anti-renal cell carcinoma x antichelate bispecific monoclonal antibodies for two-phase targeting of renal cell carcinoma.
Kranenborg MH; Boerman OC; Oosterwijk-Wakka JC; de Weijert MC; Corstens FH; Oosterwijk E
Cancer Res; 1995 Dec; 55(23 Suppl):5864s-5867s. PubMed ID: 7493361
[TBL] [Abstract][Full Text] [Related]
18. Influence of IGF-IR stimulation or blockade on proliferation of human renal cell carcinoma cell lines.
Rosendahl A; Forsberg G
Int J Oncol; 2004 Nov; 25(5):1327-36. PubMed ID: 15492822
[TBL] [Abstract][Full Text] [Related]
19. Integrins and laminins in human renal carcinoma cells and tumors grown in nude mice.
Korhonen M; Sariola H; Gould VE; Kangas L; Virtanen I
Cancer Res; 1994 Aug; 54(16):4532-8. PubMed ID: 8044804
[TBL] [Abstract][Full Text] [Related]
20. Identification of constitutive and gamma-interferon- and interleukin 4-regulated proteins in the human renal carcinoma cell line ACHN.
Sullivan CM; Smith DM; Matsui NM; Andrews LE; Clauser KR; Chapeaurouge A; Burlingame AL; Epstein LB
Cancer Res; 1997 Mar; 57(6):1137-43. PubMed ID: 9067284
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
